ANGELA ALLEN: Open Payments
NPI 1740882117 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,004 in 40 payments from 11 companies in 2025. Trend: 2023 $672 · 2024 $1,146 · 2025 $1,004
Food & beverage: $1,004
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $216 |
| AstraZeneca Pharmaceuticals LP | 2 | $182 |
| ABBVIE INC. | 9 | $153 |
| PFIZER INC. | 6 | $106 |
| Phathom Pharmaceuticals, Inc. | 3 | $96 |
| Axsome Therapeutics, Inc. | 5 | $89 |
| GlaxoSmithKline, LLC. | 3 | $52 |
| Collegium Pharmaceutical, Inc. | 2 | $41 |
| Exact Sciences Corporation | 2 | $35 |
| Globus Medical, Inc. | 1 | $18 |
Products named: Ozempic, FARXIGA, VRAYLAR, VOQUEZNA, Auvelity, PREVNAR 20, TRELEGY ELLIPTA, XTAMPZA.
Industry payments across KY — which companies pay providers there.
